since infections with herpetoviridae after kidney transplantation still remain a major clinical problem , we conducted a double-blind , placebo-controlled trial using low-dose recombinant interferon-alpha-2c ( rifna2c ) prophylaxis in 50 renal graft recipients immunosuppressed with cyclosporine and methylprednisolone .
C0022671
kidney transplantation
C0022646
renal